日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Taurine from tumour niche drives glycolysis to promote leukaemogenesis

肿瘤微环境中的牛磺酸驱动糖酵解,从而促进白血病发生。

Sonali Sharma # ,Benjamin J Rodems # ,Cameron D Baker # ,Christina M Kaszuba # ,Edgardo I Franco ,Bradley R Smith ,Takashi Ito ,Kyle Swovick ,Kevin Welle ,Yi Zhang ,Philip Rock ,Francisco A Chaves ,Sina Ghaemmaghami ,Laura M Calvi ,Archan Ganguly ,W Richard Burack ,Michael W Becker ,Jane L Liesveld ,Paul S Brookes ,Joshua C Munger ,Craig T Jordan ,John M Ashton ,Jeevisha Bajaj

B Cell Activating Factor Induces Drug Resistance in Hairy Cell Leukemia Variant

B细胞激活因子诱导毛细胞白血病变异株产生耐药性

Claire Fritz ,Daniel Feinberg ,Akshaya Radhakrishnan ,Kayla Klatt ,E Ricky Chan ,Philip Rock ,Richard Burack ,Reshmi Parameswaran

Cell therapy for a rare disease- hairy cell leukemia variant

罕见疾病——毛细胞白血病的细胞疗法

Claire Fritz, Derek P Wong, Philip Rock, Richard Burack, Akshaya Radhakrishnan, Reshmi Parameswaran

Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target

Musashi 2 影响慢性淋巴细胞白血病细胞的存活和生长,使其成为潜在的治疗靶点

Florencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, Shih-Shih Chen, Stefano Vergani, Xuejing Yang, Jeffrey Gardner, Jaqueline C Barrientos, Philip Rock, Richard Burack, Jonathan E Kolitz, Steven L Allen, Michael G Kharas, Omar Abdel-Wahab, Kanti R Rai, Nicholas Chiorazzi

Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia

糖蛋白 V 是免疫性血小板减少症患者的相关免疫靶点

Richard Vollenberg, Rabie Jouni, Peter A A Norris, Monika Burg-Roderfeld, Nina Cooper, Mathias J Rummel, Gregor Bein, Irene Marini, Behnaz Bayat, Richard Burack, Alan H Lazarus, Tamam Bakchoul, Ulrich J Sachs

Increased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodes

人类反应性和类风湿性关节炎淋巴结中 CD23(+) CD21(hi) Bin 样 B 细胞数量增加

Igor I Kuzin, Stephen L Kates, Yawen Ju, Longze Zhang, Homaira Rahimi, Wojciech Wojciechowski, Steven H Bernstein, Richard Burack, Edward M Schwarz, Andrea Bottaro

Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline

强力霉素抑制 COP9 信号体 (CSN) 去乙酰基化活性和弥漫性大 B 细胞淋巴瘤的肿瘤生长

Mary Pulvino, Luojing Chen, David Oleksyn, Jing Li, George Compitello, Randy Rossi, Stephen Spence, Vijaya Balakrishnan, Craig Jordan, Brian Poligone, Carla Casulo, Richard Burack, Joel L Shapiro, Steven Bernstein, Jonathan W Friedberg, Raymond J Deshaies, Hartmut Land, Jiyong Zhao